Abstract
Objective To observe the efficacy of alphrostadil injection on patients with decompensated cirrhosis. Methods A toatal of 112 patients with decompensated cirrhosis were selected and randomly divided into treatment group and control group, with 56 cases in each group. The patients in control group were treated with conventional liver protection and support treatment, while the patients in treatment group were given alphrostadil injection on the basis of conventional treatment. The changes of liver function index including alanine aminotransferase(ALT), total bilirubin(TBIL), albumin(ALB), prothrombin cativity(PTA), ascites and complications were compared. Results The levels of ALT, TBiL were significant decreased and the levels of ALB, PTA were increased after treatment in both groups(P 0.05). Conclusions Alphrostadil can improve the liver function of patients with liver cirrhosis, it had considerable effects on decompensated cirrhosis. Key words: Alphrostadil; Liver cirrhosis; Liver function
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
